US Stock MarketDetailed Quotes

PIRS Pieris Pharmaceuticals

Watchlist
  • 11.1600
  • -0.0800-0.71%
Trading May 3 10:20 ET
13.80MMarket Cap-516P/E (TTM)

Pieris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
65.28%42.81M
-77.78%1.3M
263.50%19.52M
442.32%20.06M
-82.38%1.94M
-17.56%25.9M
-30.76%5.85M
32.36%5.37M
12.57%3.7M
-29.71%10.99M
Operating revenue
65.28%42.81M
-77.78%1.3M
263.50%19.52M
442.32%20.06M
-82.38%1.94M
-17.56%25.9M
-30.76%5.85M
32.36%5.37M
12.57%3.7M
-29.71%10.99M
Cost of revenue
Gross profit
Operating expense
-10.07%55.04M
-51.47%6.78M
2.27%16.43M
10.54%16.41M
-5.49%15.42M
-23.08%61.2M
-23.83%13.97M
-24.47%16.07M
-22.89%14.84M
-21.15%16.32M
Selling and administrative expenses
2.80%16.85M
-41.61%2.33M
73.18%6.84M
-10.22%3.66M
-8.13%4.02M
-1.20%16.39M
-2.45%3.99M
-4.43%3.95M
-3.89%4.08M
6.03%4.38M
-General and administrative expense
2.80%16.85M
-41.61%2.33M
73.18%6.84M
-10.22%3.66M
-8.13%4.02M
-1.20%16.39M
-2.45%3.99M
-4.43%3.95M
-3.89%4.08M
6.03%4.38M
Research and development costs
-21.10%41.8M
-66.71%4.45M
-29.39%9.6M
19.93%14.33M
-4.56%13.42M
-20.51%52.98M
-12.87%13.38M
-28.24%13.59M
-24.39%11.95M
-15.07%14.07M
Other operating expenses
55.81%-3.61M
--0
----
-33.78%-1.58M
4.79%-2.03M
-121.79%-8.17M
-209.68%-3.39M
18.17%-1.47M
-48.74%-1.18M
---2.13M
Operating profit
65.35%-12.23M
32.55%-5.48M
128.84%3.09M
132.72%3.65M
-153.11%-13.48M
26.68%-35.3M
17.93%-8.13M
37.86%-10.7M
30.18%-11.15M
-5.30%-5.33M
Net non-operating interest income expense
156.73%1.85M
29.63%455K
127.80%549K
271.21%490K
12,000.00%357K
17,925.00%721K
5,950.00%351K
5,925.00%241K
4,300.00%132K
-200.00%-3K
Non-operating interest income
156.73%1.85M
29.63%455K
127.80%549K
271.21%490K
--357K
17,925.00%721K
5,950.00%351K
5,925.00%241K
4,300.00%132K
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
--3K
Other net income (expense)
-1,186.88%-14.16M
236.31%443K
-2,089.90%-14.39M
-123.82%-161K
-124.89%-57K
-45.80%1.3M
-185.98%-325K
6.64%723K
45.69%676K
-74.10%229K
Special income (charges)
---13.91M
--981K
---14.89M
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--13.91M
---981K
--14.89M
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
-119.19%-250K
-65.54%-538K
-30.01%506K
-123.82%-161K
-124.89%-57K
-45.80%1.3M
-185.98%-325K
6.64%723K
45.69%676K
-74.10%229K
Income before tax
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
33.29%-10.34M
-22.27%-5.1M
Income tax
Net income
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
33.29%-10.34M
-22.27%-5.1M
Net income continuous Operations
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
33.29%-10.34M
-22.27%-5.1M
Minority interest income
Net income attributable to the parent company
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
33.29%-10.34M
-22.27%-5.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
41.12%-9.74M
33.29%-10.34M
-22.27%-5.1M
Basic earnings per share
40.00%-21.6
63.64%-3.2
15.38%-8.8
135.71%4
-157.14%-14.4
36.62%-36
15.38%-8.8
45.83%-10.4
44.00%-11.2
0.00%-5.6
Diluted earnings per share
40.00%-21.6
63.64%-3.2
15.38%-8.8
135.71%4
-157.14%-14.4
36.62%-36
15.38%-8.8
45.83%-10.4
44.00%-11.2
0.00%-5.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 65.28%42.81M-77.78%1.3M263.50%19.52M442.32%20.06M-82.38%1.94M-17.56%25.9M-30.76%5.85M32.36%5.37M12.57%3.7M-29.71%10.99M
Operating revenue 65.28%42.81M-77.78%1.3M263.50%19.52M442.32%20.06M-82.38%1.94M-17.56%25.9M-30.76%5.85M32.36%5.37M12.57%3.7M-29.71%10.99M
Cost of revenue
Gross profit
Operating expense -10.07%55.04M-51.47%6.78M2.27%16.43M10.54%16.41M-5.49%15.42M-23.08%61.2M-23.83%13.97M-24.47%16.07M-22.89%14.84M-21.15%16.32M
Selling and administrative expenses 2.80%16.85M-41.61%2.33M73.18%6.84M-10.22%3.66M-8.13%4.02M-1.20%16.39M-2.45%3.99M-4.43%3.95M-3.89%4.08M6.03%4.38M
-General and administrative expense 2.80%16.85M-41.61%2.33M73.18%6.84M-10.22%3.66M-8.13%4.02M-1.20%16.39M-2.45%3.99M-4.43%3.95M-3.89%4.08M6.03%4.38M
Research and development costs -21.10%41.8M-66.71%4.45M-29.39%9.6M19.93%14.33M-4.56%13.42M-20.51%52.98M-12.87%13.38M-28.24%13.59M-24.39%11.95M-15.07%14.07M
Other operating expenses 55.81%-3.61M--0-----33.78%-1.58M4.79%-2.03M-121.79%-8.17M-209.68%-3.39M18.17%-1.47M-48.74%-1.18M---2.13M
Operating profit 65.35%-12.23M32.55%-5.48M128.84%3.09M132.72%3.65M-153.11%-13.48M26.68%-35.3M17.93%-8.13M37.86%-10.7M30.18%-11.15M-5.30%-5.33M
Net non-operating interest income expense 156.73%1.85M29.63%455K127.80%549K271.21%490K12,000.00%357K17,925.00%721K5,950.00%351K5,925.00%241K4,300.00%132K-200.00%-3K
Non-operating interest income 156.73%1.85M29.63%455K127.80%549K271.21%490K--357K17,925.00%721K5,950.00%351K5,925.00%241K4,300.00%132K----
Non-operating interest expense --------------------------------------3K
Other net income (expense) -1,186.88%-14.16M236.31%443K-2,089.90%-14.39M-123.82%-161K-124.89%-57K-45.80%1.3M-185.98%-325K6.64%723K45.69%676K-74.10%229K
Special income (charges) ---13.91M--981K---14.89M----------0--0--0--------
-Less:Impairment of capital assets --13.91M---981K--14.89M----------0--0--0--------
Other non- operating income (expenses) -119.19%-250K-65.54%-538K-30.01%506K-123.82%-161K-124.89%-57K-45.80%1.3M-185.98%-325K6.64%723K45.69%676K-74.10%229K
Income before tax 26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M33.29%-10.34M-22.27%-5.1M
Income tax
Net income 26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M33.29%-10.34M-22.27%-5.1M
Net income continuous Operations 26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M33.29%-10.34M-22.27%-5.1M
Minority interest income
Net income attributable to the parent company 26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M33.29%-10.34M-22.27%-5.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M41.12%-9.74M33.29%-10.34M-22.27%-5.1M
Basic earnings per share 40.00%-21.663.64%-3.215.38%-8.8135.71%4-157.14%-14.436.62%-3615.38%-8.845.83%-10.444.00%-11.20.00%-5.6
Diluted earnings per share 40.00%-21.663.64%-3.215.38%-8.8135.71%4-157.14%-14.436.62%-3615.38%-8.845.83%-10.444.00%-11.20.00%-5.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg